GENEVA, April 27 -- JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (No. 7 Kunlunshan Road, Economic And Technological Development Zone,Lianyungang, Jiangsu 222047), 江苏恒瑞医药股份有限公司 (中国江苏省连云港市经济技术开发区昆仑山路7号) filed a patent application (PCT/CN2025/128335) for "USE OF ANTI-NECTIN-4 ANTIBODY DRUG CONJUGATE IN TREATMENT OF TUMORS" on Oct 17, 2025. With publication no. WO/2026/082153, the details related to the patent application was published on Apr 23, 2026.
Notably, the patent application was submitted under the Internationa...